Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

VX 745, Tocris Bioscience™

Catalog No. 391550
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Potent and selective p38α inhibitor

VX 745 is a highly potent and selective p38α/MAPK14 inhibitor, also inhibits p38β (IC50 values are 10 nM and 220 nM respectively). VX 745 blocks TNFα production in LPS-stimulated HWB in vitro (IC50 = 51-180 nM). Also reduces phosphorylation of p38MAPKα and the downstream target Hsp27, leading to vasodilation, reduces IL-1β levels and amyloid plaques in cortex and hippocampus and lowers CSF tau levels in vivo.

Chemical Identifiers

CAS 209410-46-8
Molecular Formula C19H9Cl2F2N3OS
Molecular Weight (g/mol) 436.26
MDL Number MFCD09834070
InChI Key VEPKQEUBKLEPRA-UHFFFAOYSA-N
Synonym 5-2,6-dichlorophenyl-2-2,4-difluorophenyl thio-6h-pyrimido 1,6-b pyridazin-6-one, neflamapimod, unii-tyl52qm320, 5-2,6-dichlorophenyl-2-2,4-difluorophenylthio-6h-pyrimido 1,6-b pyridazin-6-one, neflamapimod usan, 5-2,6-dichlorophenyl-2-2,4-difluorophenyl sulfanylpyrimido 1,6-b pyridazin-6-one, 5-2,6-dichlorophenyl-2-2,4-difluorophenyl sulfanylpyridazino 6,1-f pyrimidin-6-one, 5-2,6-dichlorophenyl-2-2,4-difluorophenyl sulfanyl-6h-pyrimido 1,6-b pyridazin-6-one
PubChem CID 3038525
IUPAC Name 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one
SMILES FC1=CC=C(SC2=NN3C=NC(=O)C(=C3C=C2)C2=C(Cl)C=CC=C2Cl)C(F)=C1

Specifications

Quantity 50 mg
Formula Weight 436.26
Percent Purity >98%
Chemical Name or Material VX 745
Recommended Storage Store at -20°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.